admission date:  [2165-12-18]              discharge date:   [2165-12-24]date of birth:  [2114-7-6]             sex:   mservice: surgeryallergies:sulfa (sulfonamides)attending:[first name3 (lf) 5569]chief complaint:hcv here for liver transplantmajor surgical or invasive procedure:[2165-12-18] liver transplanthistory of present illness:51 y/o male who is originally from the [location (un) 3156] where he believeshe acquired the hcv in [2137] when he received a bloodtransfusion. the hcv was diagnosed in [2158] and he has undergonemultiple interferon-based therapies including interferonmonotherapy, rebetron, and peg-intron and ribavirin withoutachieving an evr or svr. he was part of the copilot maintenancearm trial in [2160] and in fall of [2163] had  complete viralsuppression.  he has been off of all antihcv therapies now forthe past 18 months and has had no hcv viremiaon his labwork. he recently underwent surveillance ct whichdemonstrated  a known lesion had increased slightly to 15mm insize. the cts were to be repeated q 3 months. patient deniesrecent illnesses, no chest pain, sob, n/v/d has occasional rightsided discomfort not decribed as painpast medical history:hcv / hcc with portal hypertensionosteomyelitis s/p leg fracture [2137].psh:multiple lithotripsies for kidney stonessocial history:past etoh use, now quit, no tobacco or ivdulives with wife and has two grown sons.family history:mother with [name (ni) 2320], no liver diseasephysical exam:vs: 97.3, 93, 124/83, 16, 97%rageneral: appears well, nadheent: perrla, no ladcard: rrr, no m/r/glungs: cta bilaterallyabd: soft, non distended non-tender, +bs, no surgical scarsextrem: 2+ bilateral lower extremity edemaneuro: a+ox3, no focal deficitskin: no rashes.pertinent results:[2165-12-24] 05:40am blood wbc-6.7 rbc-2.75 hgb-9.0 hct-26.7mcv-97 mch-32.9 mchc-33.8 rdw-19.1 plt ct-67[2165-12-24] 05:40am blood pt-13.8 ptt-28.7 inr(pt)-1.2[2165-12-24] 05:40am blood glucose-90 urean-21 creat-0.7 na-136k-3.3 cl-101 hco3-28 angap-10[2165-12-18] 02:25pm blood alt-23 ast-44 alkphos-139 totbili-3.0[2165-12-24] 05:40am blood alt-215 ast-48 alkphos-66 totbili-0.9[2165-12-24] 05:40am blood albumin-2.8 calcium-8.0 phos-3.7 mg-1.6brief hospital course:on [2165-12-18], he underwent liver transplant. surgeon as dr. [first name8 (namepattern2) ][last name (namepattern1) ]. induction immunosuppression was administered. pleaserefer to operative note for complete details. two jps wereplaced.  during dissection a small defect was made in thediaphragm.  this was closed with a figure-of-eight silk sutureafter evacuating the pneumothorax using a red rubber catheterplaced to suction. he did very well and was transferred to thesicu postop for management. a cxr demonstrated a increased sizeof right apical pneumothorax and right upper lobe collapse. achest tube was placed with improvement. chest tube was removedon [12-21]. postop lfts initially increased then trended downdaily. he remained hemodynamically stable. jp drains werenon-bilious. postop, liver duplex showed patent vasculature andno ductal dilatation.he was transferred out of the sicu to the med-[doctor first name ] unit where hemade daily progress. diet was advanced and tolerated. herequired insulin sliding scale for hyperglycemia secondary tosteroids. he became independent with ambulation. jps wereremoved. he did well with immunosuppression teaching. steroidswere tapered per protocol. cellcept was well tolerated. prografwas initiated on postop day 0. trough levels were done dailywith dose adjustments. prograf was increased to 9mg [hospital1 ] for atrough of 5 on [12-24].he experienced intractable hiccoughs as a result of thediaphragm repair. he did receive a couple low doses of thorazinewith temporary relief.due to sulfa allergy, bactrim was not ordered for pcp[name initial (pre) 1102]. he received a pentamidine inhalation treatment on[12-23]. he also received a pamidronate treatment on [12-24] forosteopenia.he was discharged home with instructions to check his bloodsugar prior to breakfast and supper. he will follow up in theoutpatient clinic on [1-2]. labs will be drawn on [12-26].medications on admission:clotrimazole 10 mg 5x dailyfurosemide 20 mg dailypropranolol 10 mg qdspironolactone 50 mg daily(verified with patient. recent changes in omr not initiated yetper patienttylenol pm prndischarge medications:1. fluconazole 200 mg tablet sig: two (2) tablet po q24h (every24 hours).2. prednisone 20 mg tablet sig: one (1) tablet po daily (daily):follow taper.3. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2times a day).4. famotidine 20 mg tablet sig: one (1) tablet po bid (2 times aday).5. metoprolol tartrate 25 mg tablet sig: one (1) tablet po tid(3 times a day).disp:90 tablet(s) refills:26. mycophenolate mofetil 500 mg tablet sig: two (2) tablet pobid (2 times a day).7. valganciclovir 450 mg tablet sig: two (2) tablet po daily(daily).8. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets poq4h (every 4 hours) as needed for pain.disp:30 tablet(s) refills:0discharge disposition:homedischarge diagnosis:hcvhccs/p orthotopic liver transplantdischarge condition:goodalert, orientedtolerating regular dietambulating with supervisiondischarge instructions:please call the transplant office [telephone/fax (1) 673] if have anydanger signs (see below)take all medication as prescribed and indicated on yourmedication sheetyou will need to have labs drawn every monday and thursday am at[last name (namepattern1) 439] labfollowup instructions:[name6 (md) ] [last name (namepattern4) 2424], md phone:[telephone/fax (1) 2422] date/time:[2165-12-31] 8:45[last name (lf) ],[first name3 (lf) 156] transplant social work date/time:[2166-1-2] 2:30[first name11 (name pattern1) 674] [last name (namepattern4) 675], md phone:[telephone/fax (1) 673] date/time:[2166-1-2] 3:10provider: [first name11 (name pattern1) 819] [last name (namepattern4) 820], md phone:[telephone/fax (1) 673] date/time:[2166-1-9]10:00